Patent · US Active

CCR2 antagonists

US8962656B2 · kind B2 · utility

9Cited by

22References

15Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Heiner Ebel · Biberach an der Riß, DE
Sara Frattini · Castelleone, IT
Riccardo Giovannini · Verona, IT
Christoph Hoenke · Ingelheim am Rhein, DE
Stefan Scheuerer · Warthausen, DE

Key dates

Filing date	May 26, 2011
Grant date	Feb 24, 2015
Priority date	—
Expiry date	May 26, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of formula (Ia) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.